Aesyra is a clinical-stage medical device company and a spin-off of the Federal Institute of Technology Lausanne (EPFL) that has developed the AesyBite® line of oral appliances. Its system combines an intraoral appliance, proprietary sensors, and AI-driven algorithms trained on over 10 years of sleep research data to measure multiple factors during sleep. The company reports its technology has demonstrated over a 70% reduction in bruxism activity for users. Aesyra intends to use new funding to support further development and the commercialization of the AesyBite products and to accelerate deployment. The company is led by founder and CEO Marco Letizia and is based in Lausanne, Switzerland. Aesyra positions its product as an active, sensor- and algorithm-driven approach to improving patient outcomes for bruxism and sleep apnea. Aesyra is developing AesyBite™, a medical device intended to accurately monitor and actively relieve sleep bruxism. The company has secured intellectual property, developed prototypes and obtained clinical data supporting its technology. Management says the new financing will fund industrialization, clinical validation and commercialization of the product. Aesyra’s technology has multiple applications in dentistry and sleep medicine and the company sees significant partnering opportunities. It works closely with medical experts at the Clinique Universitaire de Médecine Dentaire de Genève and leading opinion leaders in bruxism, dental implantology and sleep medicine. Aesyra is a spin-off of the Laboratory of Life Sciences Electronics at EPFL and is based in Lausanne, Switzerland.

Total raised

$3M

Funding rounds

2

Latest round

Seed

Latest activity

Dec 2023